αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
about
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinomaalphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.αB-crystallin: a novel regulator of breast cancer metastasis to the brainExpression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinomaExpression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinomaHigh level of αB-crystallin contributes to the progression of osteosarcomaαB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic targetαB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis.HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance.Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues.Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
P2860
Q21261248-7B0215BC-404A-4F88-AE28-7363AC0F41A4Q33830446-934A32F6-586D-4333-9E8E-DD13C05247C2Q33932784-0D7BC437-C618-49F2-BEA4-E52424A75AB7Q34378205-0A1828CE-4A1A-4D1C-A0CD-EDB1FF7EE445Q34413448-034CB5EB-FBC8-4340-AC53-D86C9474D74EQ34462869-3E8A29DE-1D74-4AA2-842C-6E20C973F353Q34626414-43C237F4-B0B1-40ED-91C7-E96CC66F185EQ36095069-E8665179-DAAB-46A3-8A46-8304E0EDF02CQ36962484-F277255D-9B01-4658-8BA9-9E97D84F434DQ37241367-AA4E3D6D-3CBA-4058-83D3-E6C3FA308A24Q37265368-74388637-0032-4BCD-ADE1-AFC1AF0D0BB8Q38671885-4FFA8B98-CBFC-4663-8F3D-EDA2673AE032Q38709890-69363B3E-1FD5-4E8A-AC23-FE7FFFF36C74Q39664604-2A55C349-67BE-4700-9235-4CBA684D0618Q43699188-E76C1527-482D-47BE-9C38-0D9DA108689DQ54209308-43A9CF31-5668-41A1-B285-69F94965964AQ55493581-5C8F8218-33C6-431A-BD84-43BFEDE76FED
P2860
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@ast
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@en
type
label
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@ast
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@en
prefLabel
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@ast
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@en
P2093
P2860
P356
P1476
αB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.
@en
P2093
Hae Sung Kim
Hee Joon Kang
Lee Su Kim
Young Ah Lim
Younok Lee
P2860
P356
10.4048/JBC.2011.14.1.14
P577
2011-03-31T00:00:00Z